Based on the information provided, review of the surgical technique guide, ifu, certificates of conformance and fmea, there is no indication of device failure and no indication that the device was out of specification.The most probable root cause for the fracture could not be determined.Bone fracture is a known risk of placement of metallic devices into pelvic bone.Initial ifuse procedure on 04/26/2021 (bilateral): left: ifuse-3d implant, p/n 7060m-90, lot# 2765071, mfd.(b)(6)2020, exp.2025-01-12, gtin (b)(6).Right: ifuse-3d implant, p/n 7060m-90, lot# 2760611, mfd.(b)(6)2020, exp.2025-10-20, gtin (b)(6).
|
In (b)(6) 2023, si-bone reviewed clinical study adverse events and made the decision to report this adverse event although it is unknown if the implants were the cause of the adverse event.The patient had spine fusion along with the installation of ifuse implants in (b)(6) 2021.Approximately 45 days post-op, the patient presented with sacral fractures.The patient underwent two revisions in (b)(6) 2021 and (b)(6) 2022 where sacral screws were replaced.The ifuse implants were not adjusted or removed.Bone fracture is a known risk of placement of metallic devices into pelvic bone.
|